Delivery Order SPE2DB25D3005-SPE2DB25FQHPY
Award Date 8/5/25
Potential Completion Date 8/6/25
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Ibsrela 50 mg tablets (60-count unit) valued at $1,926.04. This firm fixed-price contract, which reaches completion on August 6, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026. The delivery order carries no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Ibsrela 50 mg tablets (60 count) under a firm fixed-price contract valued at $4,847.75. This non-set-aside award is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion vehicle that runs through December 2026 and supports pharmaceutical procurement for military and veteran...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $26,193.92 by the Defense Logistics Agency on August 7, 2025, for the supply of Ibsrela 50 mg tablets in quantities of 60 units. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 8, 2025. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,479.50 to AmerisourceBergen Drug Corp for the supply of Ibsrela 50 mg tablets in quantities of 60 units. This firm fixed-price, competitively awarded contract was issued on August 1, 2025, with an ultimate completion date of August 4, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $10,143.48 to AmerisourceBergen Drug Corp for 60 tablets of Ibsrela 50 mg, to be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This firm fixed price delivery order, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a non-set-aside competitive award and is classified as a child contract under a larger vehicle. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,266.36 by the Defense Logistics Agency (DLA) on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract, which is not set-aside and competitively awarded, calls for the delivery of Ibsrela 50 mg tablets in quantities of 60 units. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies totaling $3,425.94, with completion scheduled for August 18, 2025. This non-set-aside, competitively awarded contract covers the supply of Ibsrela 50 mg tablets (60-count units) to be delivered to the contractor's facility in Conshohocken, Pennsylvania. The award employs firm fixed pricing under a delivery order contract type, reflecting the standardized procurement approach...
- The Defense Logistics Agency awarded a delivery order valued at $2,898.52 to AmerisourceBergen Drug Corp for IBSRELA 50 MG tablets (60-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a $10,409.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This non-competitive delivery order was performed at the contractor's corporate office location in Conshohocken, Pennsylvania, and represents a routine pharmaceutical procurement supporting federal medical supply needs. The award is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $13,445.69 to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was awarded on a competitive basis with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...